TABLE OF CONTENTS
Volume 36, Issue 6 (September (2) 2005)
Editorial
Comorbidity and beyond: pre-transplant clinical assessment FREE
A S Artz
Bone Marrow Transplant 36: 473-474; doi:10.1038/sj.bmt.1705042
Review
Comorbidity indices in hematopoietic stem cell transplantation: a new report card FREE
J Alamo, M Shahjahan, H M Lazarus, M de Lima and S A Giralt
Bone Marrow Transplant 36: 475-479; advance online publication, July 4, 2005; doi:10.1038/sj.bmt.1705041
Original Articles
Hourly monitoring of circulating CD34+ cells to optimize timing of autologous apheresis in pediatric patients FREE
K Bochennek, C Andreas, C Margraf, H Stahlkamp, S Zimmermann, R Esser, D Schwabe, T Klingebiel, H-P Grüttner and U Koehl
Bone Marrow Transplant 36: 481-489; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705098
Pilot study of tandem high-dose chemotherapy and autologous stem cell transplantation with a novel combination of regimens in patients with poor risk lymphoma FREE
K P Papadopoulos, W Noguera-Irizarry, L Wiebe, C S Hesdorffer, J Garvin, G L Nichols, L H Vahdat, K M S Lo, D Skerrett, D Bernstein, E Sharpe and D G Savage
Bone Marrow Transplant 36: 491-497; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705103
Transfusion of leukoreduced cellular blood components from cytomegalovirus-unscreened donors in allogeneic hematopoietic transplant recipients: analysis of 72 recipients FREE
A B Narvios, M de Lima, H Shah and B Lichtiger
Bone Marrow Transplant 36: 499-501; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705090
The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation FREE
S Giebel, R Maccario, D Lilleri, M Zecca, M A Avanzini, M Marconi, A Di Cesare Merlone, G Campanini, D Montagna, P Travaglino, R Gentile, S Telli, D Pagliara, J Holowiecki and F Locatelli
Bone Marrow Transplant 36: 503-509; advance online publication, July 11, 2005; doi:10.1038/sj.bmt.1705094
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation FREE
B M Svahn, O Ringdén and M Remberger
Bone Marrow Transplant 36: 511-516; advance online publication, July 18, 2005; doi:10.1038/sj.bmt.1705096
Intestinal thrombotic microangiopathy following reduced-intensity umbilical cord blood transplantation FREE
H Narimatsu, M Kami, S Hara, T Matsumura, S Miyakoshi, E Kusumi, Y Kakugawa, Y Kishi, N Murashige, K Yuji, K Masuoka, A Yoneyama, A Wake, S Morinaga, Y Kanda and S Taniguchi
Bone Marrow Transplant 36: 517-523; advance online publication, July 18, 2005; doi:10.1038/sj.bmt.1705099
Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML FREE
J Y Sun, L Gaidulis, A Dagis, J Palmer, R Rodriguez, M M Miller, S J Forman and D Senitzer
Bone Marrow Transplant 36: 525-530; advance online publication, July 18, 2005; doi:10.1038/sj.bmt.1705089
Reduced risk of acute GVHD following mobilization of HLA-identical sibling donors with GM-CSF alone FREE
S M Devine, R A Brown, V Mathews, K Trinkaus, H Khoury, D Adkins, R Vij, D Sempek, T Graubert, M Tomasson, L T Goodnough and J F DiPersio
Bone Marrow Transplant 36: 531-538; advance online publication, July 18, 2005; doi:10.1038/sj.bmt.1705091
Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease FREE
G de Lissovoy, D Hurd, S Carter, P Beatty, M Ewell, J Henslee-Downey, N Kernan, S Yanovich and D Weisdorf
Bone Marrow Transplant 36: 539-546; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705078
Cost effectiveness of day 5 G-CSF (Lenograstim®) administration after PBSC transplantation: results of a SFGM-TC randomised trial FREE
D Valteau-Couanet, C Faucher, A Aupérin, J Michon, N Milpied, J M Boiron, J H Bourhis, C Gisselbrecht, J P Vernant, A Pinna, B Bendahmane, F Delabarre and E Benhamou
Bone Marrow Transplant 36: 547-552; advance online publication, July 11, 2005; doi:10.1038/sj.bmt.1705097
Correspondence
A prognostic model for prolonged event-free survival after autologous or allogeneic blood or marrow transplantation for relapsed and refractory Hodgkin's disease FREE
S Tey, J Butler, S Durrant, G Hill, J Morton and G Kennedy
Bone Marrow Transplant 36: 553-554; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705044
Response to Tey et al FREE
T Hahn and P L McCarthy Jr
Bone Marrow Transplant 36: 554; advance online publication, July 25, 2005; doi:10.1038/sj.bmt.1705045
Successful engraftment in crossmatch-positive HLA-mismatched peripheral blood stem cell transplantation after depletion of antidonor cytotoxic HLA antibodies with rituximab and donor platelet infusion FREE
H Narimatsu, A Wake, Y Miura, H Tanaka, T Matsumura, S Takagi, D Kato, T Myojo, E Kusumi, K Masuoka, S Miyakoshi, S Morinaga, H Saji, T Ichinohe and S Taniguchi
Bone Marrow Transplant 36: 555-556; advance online publication, July 11, 2005; doi:10.1038/sj.bmt.1705070
Culture of bone marrow CD105+ cells allows rapid selection of pure BM-stromal cells for chimerism studies in patients undergoing allogeneic bone marrow transplantation FREE
E Goussetis, A Spiropoulos, M Theodosaki, G Paterakis, I Peristeri, V Kitra, E Petrakou, A Soldatou and S Graphakos
Bone Marrow Transplant 36: 557-559; advance online publication, July 18, 2005; doi:10.1038/sj.bmt.1705083
Paradoxical embolism after peripheral blood stem cell infusion FREE
K Darabi, J R Brown and G S Kao
Bone Marrow Transplant 36: 561-562; advance online publication, July 11, 2005; doi:10.1038/sj.bmt.1705088
